MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Navigating therapeutic landscapes with Parkinson’s disease in a scarce biomedical healthcare setting: the case of Kenya

N. Fothergill Misbah, K. Hampshire, S. Moffatt, J. Hooker, J. Kwasa, R. Walker (Newcastle upon Tyne, United Kingdom)

Meeting: MDS Virtual Congress 2020

Abstract Number: 316

Keywords: Parkinsonism

Category: Other

Objective: To explore how people with Parkinson’s disease (PWPD) living in Kenya manage and negotiate their treatment and care within a scarce and overwhelmed biomedical health setting.

Background: The prevalence of PD continues to rise globally [1] yet research on PD in sub-Saharan Africa (SSA) is lacking. Existing research in SSA has found that treatment and rehabilitation services for PD are largely unavailable or too expensive for the majority [2, 3]. This qualitative study examines the availability and use of biomedical services and alternative healing landscapes for PD management in Kenya.

Method: Ethnographic methods including interviews and observations were applied over 9 months across urban and rural areas. Participants included patients (N=55), family members (N=22), healthcare professionals (N=13), pharmacists (N=28) and herbal doctors (N=5).

Results: No PWPD had ever seen an occupational therapist or dietician, 2 had accessed a speech and language therapist and 11 a physiotherapist. Thirteen PWPD had sought out religious healing and 8 had taken herbal medicines for PD. The cost of private neurology services was unaffordable for many yet the public neurology clinic was overwhelmed and consultations were described as “prescription only”. Basic medication for PD (levodopa/carbidopa) was largely unavailable. 100 tablets could cost up to $80 and all PWPD had to pay for this out-of-pocket. Treatment costs led many families to destitution and PWPD often spent weeks without any treatment. PWPD described drawing on a therapeutic continuum for the treatment of PD including the use of herbs, leaves, honey, supplements, prayers and healing events. Alternative treatment was expensive but offered PWPD hope of a cure when biomedicine could not.

Conclusion: The therapeutic landscape in Kenya is complex and bewildering. Both PWPD and healthcare professionals experienced a constrained agency, struggling with the constraints of service availability, medication affordability and limited information about PD, resulting in an improvised form of medicine and care. Healthcare professionals withheld prognoses from patients while religious and herbal healers sold promises of a cure, resulting in medical pluralism by PWPD. There is a great need to improve access to biomedical services and affordable medication for PWPD in Kenya and other low resource settings to prevent the suffering of untreated PD.

References: [1] E.R. Dorsey, B.R. Bloem, The Parkinson Pandemic-A Call to Action, JAMA Neurol 75(1) (2018) 9-10. [2] C. Dotchin, R. Walker, The management of Parkinson’s disease in sub-Saharan Africa, Expert review of neurotherapeutics 12(6) (2012) 661-6. [3] J. Mokaya, C.L. Dotchin, W.K. Gray, J. Hooker, R.W. Walker, The Accessibility of Parkinson’s Disease Medication in Kenya: Results of a National Survey, Movement Disorders Clinical Practice 3(4) (2016) 376-381.

To cite this abstract in AMA style:

N. Fothergill Misbah, K. Hampshire, S. Moffatt, J. Hooker, J. Kwasa, R. Walker. Navigating therapeutic landscapes with Parkinson’s disease in a scarce biomedical healthcare setting: the case of Kenya [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/navigating-therapeutic-landscapes-with-parkinsons-disease-in-a-scarce-biomedical-healthcare-setting-the-case-of-kenya/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/navigating-therapeutic-landscapes-with-parkinsons-disease-in-a-scarce-biomedical-healthcare-setting-the-case-of-kenya/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley